GARDASIL 9 susp inj ser pré 0.5 ml
7680653870019
CH-65387
J07BM03
08.08.
1 / 3
google
Details
- Product number
- 6538701
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- proteinum L1 papillomaviri humani typus 6 30 µg, proteinum L1 papillomaviri humani typus 11 40 µg, proteinum L1 papillomaviri humani typus 16 60 µg, proteinum L1 papillomaviri humani typus 18 40 µg, proteinum L1 papillomaviri humani typus 31 20 µg, proteinum L1 papillomaviri humani typus 33 20 µg, proteinum L1 papillomaviri humani typus 45 20 µg, proteinum L1 papillomaviri humani typus 52 20 µg, proteinum L1 papillomaviri humani typus 58 20 µg, aluminium ut aluminii hydroxyphosphas sulfas amorphus, natrii chloridum, histidinum, polysorbatum 80, natrii boras, aqua ad iniectabile ad suspensionem pro 0.5 ml corresp. natrium 3.78 mg.
Articles (1)
Gardasil 9, Injektionssuspension in Fertigspritze
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.78 MG | Substance | HBESI |
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 65387
- Drug name
- Gardasil 9, Injektionssuspension in Fertigspritze
- Galenic form
- INJFS
- ATC Code
- J07BM03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/07/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GARDASIL 9 sol inj 30 µg 1 pce
- Description (DE)
- GARDASIL 9 Inj Lös 30 µg 1 Stk
- Market launch
- 29/07/2016
- Narcotic (BTM)
- No